Relationship Between Cardiac Structure and Function With Renal Function Trajectory and Outcomes in Patients With Heart Failure: Insights From the PARAGON-HF Trial

被引:0
|
作者
Lu, Henri [1 ]
Chatur, Safia [1 ]
Lee, Sahmin [1 ]
Inciardi, Riccardo M. [3 ]
Abanda, Martin [1 ]
Causland, Finnian R. Mc [2 ]
Kalayci, Arzu [1 ]
Taheri, Kimia Karimi [1 ]
Shah, Amil M. [4 ]
Cikes, Maja [5 ]
Claggett, Brian L. [1 ]
Prasad, Narayana [1 ]
Lam, Carolyn S. P. [6 ,7 ]
O'Meara, Eileen [8 ]
Wang, Xiaowen [1 ]
McMurray, John J. V. [9 ]
Pfeffer, Marc A. [1 ]
Hegde, Sheila M. [1 ]
Solomon, Scott D. [1 ]
Skali, Hicham [1 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Renal Div, Dept Med, Boston, MA USA
[3] Univ Brescia, Azienda Socio Sanit Territoriale Spedali Civili Br, Radiol Sci & Publ Hlth, Dept Med & Surg Specialties, Brescia, Italy
[4] Univ Texas Southwestern Med Ctr, Div Cardiovasc Med, Dallas, TX USA
[5] Univ Zagreb, Univ Hosp Ctr Zagreb, Sch Med, Dept Cardiovasc Dis, Zagreb, Croatia
[6] Natl Heart Ctr Singapore, Singapore, Singapore
[7] Duke Natl Univ Singapore, Singapore, Singapore
[8] Univ Montreal, Montreal Heart Inst, Dept Cardiol, Quebec City, PQ, Canada
[9] Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Sch Cardiovasc & Metab Hlth, Glasgow, Scotland
关键词
glomerular filtration rate; heart failure; kidney disease; kidney failure; chronic; prognosis; CHRONIC KIDNEY-DISEASE; ASSOCIATION; DYSFUNCTION; RECOMMENDATIONS; HYPERTROPHY; SOCIETY;
D O I
10.1161/CIRCHEARTFAILURE.124.011942
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND:Renal dysfunction is common and associated with a poor prognosis in patients with heart failure. However, the association of cardiac structure and function with decline in kidney function in this population is unknown. We aimed to assess the association between individual measures of cardiac structure and function with changes in renal function and renal outcomes in patients with heart failure with preserved ejection fraction.METHODS:Patients enrolled in the PARAGON-HF (Prospective Comparison of Angiotensin Receptor-Neprilysin Inhibitor With Angiotensin-Receptor Blockers Global Outcomes in Heart Failure With Preserved Ejection Fraction) echocardiographic substudy were included. The association between each echocardiographic parameter (expressed in standardized units) and changes over time in estimated glomerular filtration rate was calculated with repeated-measures mixed-effect models. Multivariable Cox proportional hazards models were used to identify individual cardiac parameters associated with the composite renal outcome (>= 50% decline in estimated glomerular filtration rate relative to baseline, development of end-stage renal disease, or death attributable to renal causes), after adjusting for covariates.RESULTS:Among 1097 patients (mean age 74 +/- 8 years and 53% women), over a median follow-up of 2.9 years, 28 composite renal events (0.9 per 100 person-years) occurred. Higher left ventricular (LV) mass index and higher E/average e ' ratio were associated with significantly more profound annual decline in estimated glomerular filtration rate (for both, -0.4 [95% CI, -0.7 to -0.1] mL/min/1.73 m2/y per 1 higher SD). Higher LV mass index, LV end-diastolic volume index, right ventricular end-diastolic area, and a lower right ventricular fractional area change were each associated with a significantly higher risk for the composite renal outcome.CONCLUSIONS:In the PARAGON-HF echocardiographic substudy, higher LV mass and filling pressures were independently associated with more profound kidney function decline, and higher LV mass and volume, as well as impaired right ventricular structure and function, were each associated with renal events. Assessing these parameters may help identify patients with heart failure with preserved ejection fraction at higher risk for adverse renal events and indicate potential therapeutic targets.REGISTRATION:URL: https://www.clinicaltrials.gov; Unique identifier: NCT01920711.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Natriuretic peptide-based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON-HF
    Pabon, Maria A.
    Cunningham, Jonathan W.
    Claggett, Brian L.
    Packer, Milton
    Zile, Michael
    Pfeffer, Marc A.
    Lefkowitz, Martin
    Shi, Victor
    Rizkala, Adel
    McMurray, John J., V
    Solomon, Scott D.
    Vaduganathan, Muthiah
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (04) : 672 - 677
  • [42] Letter by Tuncez and Gurses Regarding Article, "Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF"
    Tuncez, Abdullah
    Gurses, Kadri Murat
    CIRCULATION, 2025, 151 (06) : e37 - e37
  • [43] Relationship between left ventricular structure and function and plasma Neurohormones in patients with heart failure: Results from the EARTH trial
    Anand, IS
    Florea, VG
    Kuskowski, MA
    Konstam, MA
    McMurray, J
    Cohn, JN
    Notter, T
    Luscher, TF
    CIRCULATION, 2003, 108 (17) : 519 - 519
  • [44] Multiparameter Right Ventricular Dysfunction Predicts Worse Prognosis in Heart Failure With Preserved Ejection Fraction - Lessons From the PARAGON-HF Trial
    Lu, Henri
    Inciardi, Riccardo M.
    Abanda, Martin
    Shah, Amil M.
    Cikes, Maja
    Claggett, Brian
    Prasad, Narayana
    Lam, Carolyn S.
    Redfield, Margaret M.
    McMurray, John J.
    Solomon, Scott
    Hegde, Sheila
    Skali, Hicham
    CIRCULATION, 2023, 148
  • [45] Cardiac function and structure in patients with chronic renal failure
    K. Schärer
    K. G. Schmidt
    M. Soergel
    Pediatric Nephrology, 1999, 13 : 951 - 965
  • [46] Cardiac function and structure in patients with chronic renal failure
    Schärer, K
    Schmidt, KG
    Soergel, M
    PEDIATRIC NEPHROLOGY, 1999, 13 (09) : 951 - 965
  • [47] Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction Insights From PARAGON-HF
    McMurray, John J., V
    Jackson, Alice M.
    Lam, Carolyn S. P.
    Redfield, Margaret M.
    Anand, Inder S.
    Ge, Junbo
    Lefkowitz, Marty P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Pfeffer, Marc A.
    Pieske, Burkert
    Rizkala, Adel R.
    Sabarwal, Shalini, V
    Shah, Amil M.
    Shah, Sanjiv J.
    Shi, Victor C.
    van Veldhuisen, Dirk J.
    Zannad, Faiez
    Zile, Michael R.
    Cikes, Maja
    Goncalvesova, Eva
    Katova, Tzvetana
    Kosztin, Anamaria
    Lelonek, Malgorzata
    Sweitzer, Nancy
    Vardeny, Orly
    Claggett, Brian
    Jhund, Pardeep S.
    Solomon, Scott D.
    CIRCULATION, 2020, 141 (05) : 338 - 351
  • [48] Clinical Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction and With Reduced Ejection Fraction According to the Prognostic Nutritional Index: Findings From PARADIGM-HF and PARAGON-HF
    Solano, Simone
    Yang, Mingming
    Tolomeo, Paolo
    Kondo, Toru
    Shen, Li
    Jhund, Pardeep S.
    Anand, Inder S.
    Desai, Akshay S.
    Lam, Carolyn S. P.
    Maggioni, Aldo P.
    Martinez, Felipe A.
    Rouleau, Jean L.
    Vaduganathan, Muthiah
    van Veldhuisen, Dirk J.
    Zannad, Faiez
    Zile, Michael R.
    Packer, Milton
    Solomon, Scott D.
    Mcmurray, John J. V.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (01):
  • [49] Sacubitril/Valsartan in Patients With Heart Failure and Deterioration of Kidney Function to Estimated Glomerular Filtration Rate Less Than 30ml/min/1.73m2: Insights From PARAGON-HF and PARADIGMHF
    Chatur, Safia
    Vaduganathan, Muthiah
    Claggett, Brian L.
    McCausland, Finnian
    Desai, Akshay S.
    Beldhuis, Iris
    Rouleau, Jean L.
    Zile, Michael R.
    Packer, Milton
    Pfeffer, Marc A.
    Lefkowitz, Martin P.
    McMurray, John J.
    Solomon, Scott D.
    CIRCULATION, 2023, 148
  • [50] Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial
    Cohen-Solal, Alain
    Kotecha, Dipak
    van Veldhuisen, Dirk J.
    Babalis, Daphne
    Boehm, Michael
    Coats, Andrew J.
    Roughton, Michael
    Poole-Wilson, Philip
    Tavazzi, Luigi
    Flather, Marcus
    EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (09) : 872 - 880